Hector Tamez1, Ravi I Thadhani. 1. Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. htamez@partners.org
Abstract
PURPOSE OF REVIEW: Vitamin D deficiency and hypertension are highly prevalent. This review will discuss the association between vitamin D deficiency and blood pressure. RECENT FINDINGS: During the past several years multiple prospective cohorts and randomized studies have been published. Recent studies have focused mostly on 25-hydroxy vitamin D, but a small number of trials used active vitamin D analog compounds. SUMMARY: Data from cross-sectional studies report that low 25-hydroxy vitamin D is associated with higher systolic blood pressure and higher incidence of hypertension. Large observational studies show a weaker, yet similar association, but they have not largely accounted for the change in vitamin D levels over time. Randomized control trials conflict with observational data probably due to differences in populations studied, doses of vitamin D used, and unmeasured confounders. Further research is needed before clinical practice recommends vitamin D prescription as treatment for hypertension in the general population.
RCT Entities:
PURPOSE OF REVIEW: Vitamin Ddeficiency and hypertension are highly prevalent. This review will discuss the association between vitamin Ddeficiency and blood pressure. RECENT FINDINGS: During the past several years multiple prospective cohorts and randomized studies have been published. Recent studies have focused mostly on 25-hydroxy vitamin D, but a small number of trials used active vitamin D analog compounds. SUMMARY: Data from cross-sectional studies report that low 25-hydroxy vitamin D is associated with higher systolic blood pressure and higher incidence of hypertension. Large observational studies show a weaker, yet similar association, but they have not largely accounted for the change in vitamin D levels over time. Randomized control trials conflict with observational data probably due to differences in populations studied, doses of vitamin D used, and unmeasured confounders. Further research is needed before clinical practice recommends vitamin D prescription as treatment for hypertension in the general population.
Authors: Fahim Abbasi; David Feldman; Michael P Caulfield; Feras M Hantash; Gerald M Reaven Journal: Am J Hypertens Date: 2014-08-19 Impact factor: 2.689
Authors: Susanne Rautiainen; Lu Wang; I-Min Lee; JoAnn E Manson; J Michael Gaziano; Julie E Buring; Howard D Sesso Journal: J Hypertens Date: 2016-08 Impact factor: 4.844
Authors: Helen Titmarsh; Scott Kilpatrick; Jennifer Sinclair; Alisdair Boag; Elizabeth F Bode; Stephanie M Lalor; Donna Gaylor; Jacqueline Berry; Nicholas X Bommer; Danielle Gunn-Moore; Nikki Reed; Ian Handel; Richard J Mellanby Journal: PLoS One Date: 2015-05-13 Impact factor: 3.240
Authors: Karani S Vimaleswaran; Alana Cavadino; Diane J Berry; Rolf Jorde; Aida Karina Dieffenbach; Chen Lu; Alexessander Couto Alves; Hiddo J Lambers Heerspink; Emmi Tikkanen; Joel Eriksson; Andrew Wong; Massimo Mangino; Kathleen A Jablonski; Ilja M Nolte; Denise K Houston; Tarunveer Singh Ahluwalia; Peter J van der Most; Dorota Pasko; Lina Zgaga; Elisabeth Thiering; Veronique Vitart; Ross M Fraser; Jennifer E Huffman; Rudolf A de Boer; Ben Schöttker; Kai-Uwe Saum; Mark I McCarthy; Josée Dupuis; Karl-Heinz Herzig; Sylvain Sebert; Anneli Pouta; Jaana Laitinen; Marcus E Kleber; Gerjan Navis; Mattias Lorentzon; Karen Jameson; Nigel Arden; Jackie A Cooper; Jayshree Acharya; Rebecca Hardy; Olli Raitakari; Samuli Ripatti; Liana K Billings; Jari Lahti; Clive Osmond; Brenda W Penninx; Lars Rejnmark; Kurt K Lohman; Lavinia Paternoster; Ronald P Stolk; Dena G Hernandez; Liisa Byberg; Emil Hagström; Håkan Melhus; Erik Ingelsson; Dan Mellström; Osten Ljunggren; Ioanna Tzoulaki; Stela McLachlan; Evropi Theodoratou; Carla M T Tiesler; Antti Jula; Pau Navarro; Alan F Wright; Ozren Polasek; James F Wilson; Igor Rudan; Veikko Salomaa; Joachim Heinrich; Harry Campbell; Jacqueline F Price; Magnus Karlsson; Lars Lind; Karl Michaëlsson; Stefania Bandinelli; Timothy M Frayling; Catharina A Hartman; Thorkild I A Sørensen; Stephen B Kritchevsky; Bente Lomholt Langdahl; Johan G Eriksson; Jose C Florez; Tim D Spector; Terho Lehtimäki; Diana Kuh; Steve E Humphries; Cyrus Cooper; Claes Ohlsson; Winfried März; Martin H de Borst; Meena Kumari; Mika Kivimaki; Thomas J Wang; Chris Power; Hermann Brenner; Guri Grimnes; Pim van der Harst; Harold Snieder; Aroon D Hingorani; Stefan Pilz; John C Whittaker; Marjo-Riitta Järvelin; Elina Hyppönen Journal: Lancet Diabetes Endocrinol Date: 2014-06-25 Impact factor: 32.069
Authors: Katharina Kienreich; Martin Grubler; Andreas Tomaschitz; Johannes Schmid; Nicolas Verheyen; Femke Rutters; Jacqueline M Dekker; Stefan Pilz Journal: Indian J Med Res Date: 2013-04 Impact factor: 2.375